Elon Musk validated the use of GLP-1 drugs in a post on X on Wednesday. But Robert F. Kennedy Jr. has said he's opposed to Americans using them to fight obesity.

Studies suggest that semaglutide reduces heart attack and stroke and may curb addiction and more. Scientists reflect on the future of GLP-1 drugs beyond weight loss.

Piper Sandler analyst Christopher Raymond maintained a Buy rating on Q32 Bio (QTTB – Research Report) today and set a price target of $20.00.

Doctors might be slow to admit it, but Ozempic and other GLP-1 drugs are making dieting and exercise obsolete.

For the past year, there has been a huge buzz about the so-called "weight loss injection". This is supposed to help people ...

Meds like Wegovy are all over the news. But are they right for you, especially if you’re older than the average user?

Researchers discovered that moderate and heavy drinkers were the most likely to reduce their alcohol consumption while using ...

They are currently approved for treating diabetes, obesity and those with a history of cardiovascular disease in people who ...

The videos include Cheryl meal-prepping salad, eggs, and vegetables; lifting weights; and walking with a smile on her face to the gym. She also shows the dark side of her journey, including footage of ...

The discontinuation of STRIDES is a rare stumble for the next-generation obesity field and comes just weeks after Amgen ...

In addition, the decline in overall obesity rate reported by the CDC isn’t the first such drop. Between 1999 and 2018, the ...

Eli Lilly and Company announced earlier this week that its popular obesity drug, Zepbound (tirzepatide) outperformed rival ...